Mechanisms of changes in renal handling of sodium following transjugular intrahepatic portal systemic stent-shunt (TIPSS)

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 11, 1996, Pages 1111-1116

  Jalan, Rajiv ^a   Redhead, Doris N ^a   Thomas, Huw W ^a   Henderson, Neil ^a   O'Rourke, Kevin ^a   Dillon, John F ^a   Williams, Brent C ^a   Hayes, Peter C ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Ascites; Cirrhosis; Cyclic guanosine monophosphate (GMP); Lithium clearance; Renin angiotensin; Sodium handling; Transjugular intrahepatic portosystemic stent shunt (TIPS, TIPSS)

Indexed keywords

ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; CREATININE; CYCLIC GMP; LITHIUM; RENIN; SODIUM ION;

ADULT; ARTICLE; ASCITES; CLINICAL ARTICLE; CREATININE CLEARANCE; ESOPHAGUS VARICES BLEEDING; FEMALE; HUMAN; KIDNEY TUBULE ABSORPTION; MALE; PLASMA RENIN ACTIVITY; PORTAL PHLEBOGRAPHY; PORTAL VEIN BLOOD PRESSURE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; SODIUM URINE LEVEL; TRANSJUGULAR INTRAHEPATIC PORTAL SYSTEMIC STENT SHUNT;

EID: 0029824126     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199611000-00015     Document Type: Article

References (36)

1. Witte MH, Witte CL, Dumont AE: Progress in liver disease: physiological factors involved in the causation of cirrhotic ascites. Gastroenterology 1971, 61:742-750.
2. Leiberman FL, Ito S, Reynolds TB: Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a spontaneous reduction in glomerular filtration rate (GFR) and a fall in GFR during drug induced diuresis. J Clin Invest 1969, 48:975-981.
3. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J: Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988, 8:1151-1157.
4. Perez-Ayuso R, Arroyo V, Camps J, Rimola A, Costa J, Gaya J, et al.: Renal kallikrein excretion in cirrhotics with ascites; relationship to renal haemodynamics. Hepatology 1984, 4:247-252.
5. MacGilchrist AJ, Craig KJ, Hayes PC, Cumming AD: Effect of serine protease inhibitor, aprotinin on systemic haemodynamics and renal function in patients with hepatic cirrhosis and ascites. Clin Sci 1994, 87:329-333.
6. Rimola A, Gines P, Arroyo V, Camps J, Perez-Ayuso RM, Quintero E: Urinary excretion of 6-keto-prostaglandin F1 , thromboxane B2, and prostaglandin E2 in cirrhosis with ascites; relationship to functional renal failure (hepatorenal syndrome). J Hepatol 1986, 3:111-117.
7. Arroyo V, Planas R, Gaya J, Deulafeu R, Rimola A, Perez-Ayuso RM, et al.: Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E in cirrhosis related to functional renal failure and sodium and water excretion. Eur J Clin Invest 1983, 13:271-277.
8. Zipser RD, Radvan GH, Kronborg I: Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome; evidence for increased vasoconstrictor and decreased vasodilator factors. Gastroenterology 1983 84:697-703.
9. Moore KP, Taylor GW, Maltby N, Dollery CTD, Williams R: Increased production of cysteinyl leukotrienes in hepatorenal syndrome. J Hepatol 1990, 11:262-271.
10. Caramelo C, Fernandex-Gallardo S, Santos JC, Inarrea P, Sanchez-Crespe M, Lopez-Novoa JM, et al.: Increased levels of PAF-acether in blood from patients with cirrhosis of the liver. Eur J Clin Invest 1987, 17:7-11.
11. Uchihara M, Izumi N, Sato C, Marumo F: Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis. Hepatology 1992, 16:95-99.
12. Lee FY, Colombato LA, Albillos A, Groszmann RJ: N-nitro-L-arginine administration corrects peripheral vasodilatation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats. Hepatology 1993, 17:84-90.
13. Claria J, Jimenez W, Ros J, Asbert, M, Castro A, Arroyo V, et al.: Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide. Hepatology 1992, 15:343-349.
14. Llach J, Gines P, Arroyo V, Salmeron JM, Gines A, Jiminez W, et al.: Effect of dipyridamole on the kidney function in cirrhosis. Hepatology 1993, 17:59-64.
15. Milani L, Merkel C, Gatta A: Renal effects of aminophylline in cirrhosis. Eur J Clin Pharmacol 1984, 24:757-760.
16. Ring-Larsen H, Hesse B, Henriksen JH, Christensen NJ: Sympathetic nervous activity and renal and systemic haemodynamics in cirrhosis - plasma norepinephrine concentration, hepatic extraction and renal release. Hepatology 1982, 2:304-310.
17. Bosch J, Arroyo V, Betriu A, Mas A, Carrilho F, Rivera F, et al.: Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology 1980, 78:92-99.
18. Barnardo DE, Summerskill WHJ, Strong CC, Baldus BP: Renal function, renin activity and endogenous vasoactive substances in cirrhosis. Am J Dig Dis 1970, 15:419-425.
19. Hayes PC, Cumming AD, Craig KJ, Watson M, Bouchier JAD: Portal and systemic hemodynamics and humoral factors in cirrhosis with and without ascites. Am J Gastroenterol 1992, 87:1433-1438.
20. Gines P, Jimenez W, Arroyo V, Navasa M, Lopez C, Tito L, et al.: Atrial natriuretic factor in cirrhosis with ascites; plasma levels, splanchnic release and cardiac extraction. Hepatology 1988, 8:636-642.
21. Salerno F, Badalamenti S, Incerti P, Capozza L, Mainardi L: Renal response to atrial natriuretic peptide in patients with advanced liver cirrhosis. Hepatology 1988, 8:21-26.
22. Bosch M, Jiminez W, Angeli P, Leivas A, Claria J, Graziotti A, et al.: Acuaretic efficacy of the K-opioid receptor against RU 51599 in cirrhotic rats with ascites. J Hepatol 1994, 21:S7.
23. LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, et al.: Creation of transjugular intrahepatic portasystemic stent shunts with the Wallstent endoprosthesis: results in 100 patients. Radiology 1993, 187:413-420.
24. Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau JM, et al.: The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994, 3:165-172.
25. Jalan R, Redhead DN, Simpson KJ, Elton RA, Hayes PC: Transjugular intrahepatic portasystemic stent-shunt (TIPSS): long term follow up. QJM 1994, 87:565-573.
26. Thomsen K: Lithium clearance: a new method for determining proximal and distal reabsorption of sodium and water. Nephron 1984, 37:217-223.
27. Ochs A, Rossle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, et al.: The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995, 332:1192-1197.
28. Quiroga J, Sangro B, Nunez M, Bilbao I, Longo J, Garcia-Villarreal L: Transjugular intrahepatic portal systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral and haemodynamic parameters. Hepatology 1995, 21:986-994.
29. LeBrec D, Giuily N, Hadengue A, Vilgrain V, Lassen C, Poynard T, et al.: Transjugular intrahepatic portosystemic shunt (TIPS) vs paracentesis for refractory ascites. Results of a randomised trial [abstract]. Hepatology 1994, 20:417.
30. Jalan R, Gooday R, O'Carroll RE, Redhead DN, Elton RA, Hayes PC: A prospective evaluation of changes in neuropsychological and liver function tests following transjugular intrahepatic portosystemic stent-shunt. J Hepatol 1995, 23:697-705.
31. Morali GA, Floras IS, Legault L, Tobe S, Skorecki KL, Blendis LM: Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during the development of ascites. Am J Med 1991, 91:383-392.
32. Billiar TR, Curran RD, Harbrecht BG, Stadier J, Williams DL, Ochoa JB, et al.: Association between synthesis and release of cGMP and nitric oxide biosynthesis by hepatocytes. Am J Physiol 1992, 262:1077-1082.
33. Moreau R, Gaudin C, Hadengue A, Braillon A, Roulot D, Bacq Y, et al.: Renal haemodynamics in patients with cirrhosis: relationship with ascites and renal failure, Nephron 1993, 65:359-363.
34. Wong F, Massie D, Hsu P, Dudley F: Renal response to a saline load in well compensated alcoholic cirrhosis. Hepadology 1994, 20:873-881.
35. Wong F, Sniderman K, Liu P, Blendis L: Dissecting the factors involved in the pathogenesis of sodium retention in cirrhosis with ascites using TIPS [abstract]. Hepatology 1995, 22:164A.
36. Epstein M, Schneider N, Befeler B: Relationship of systemic and intrarenal hemodynamics in cirrhosis. J Lab Clin Med 1977, 89:1175-1187.